SAMSARA BIOCAPITAL, LLC
CIK
1744967
Location
PALO ALTO, CA
Portfolio Value
Mid
$1,029,108,406
Diversification
Moderately concentrated
Filing Date
Global Rank
#1,477
/ 8,232
▲ 186
Top Industry
Biotechnology
99.0%
3Y Alpha vs SPY
+7.3%
Period ended 2 months ago
Filed May 15, 2026 · 30d
24 quarters · since Mar 2020
Clone Performance
Jun 2023–Jun 2026 · vs SPYHypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.
Cloned portfolio
+110.4%
SPY
+76.3%
Annualised alpha
+7.3%
Max drawdown
−53.0%
Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.
Portfolio Concentration
22 positions · as of Mar 31, 2026 · Δ vs Dec 31, 2025Top Position
32.9%
+1.6 pts
Top 5
76.6%
−2.9 pts
Top 10
92.0%
+0.3 pts
HHI
1,678
Moderately concentrated−72
Portfolio Trend
24 quarters · across all stocks
Sector Breakdown
As of Mar 31, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 100.0% | $1,029,108,406 |
Last Quarter's Activity
Export CSVSold Out
Positions the filer fully exited
1 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| CTNM | Contineum Therapeutics, Inc. | 72,245 | $825,760 | |
| No positions match the current search. | ||||
22 positions ·
$1,029,108,406 total
· as of Mar 31, 2026
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| SRRK |
Scholar Rock Holding Corp
Healthcare
|
Held | 6,897,652 | $339,088,572 | 32.95% | |
| MLYS |
Mineralys Therapeutics, Inc.
Healthcare
|
Held | 5,871,018 | $159,045,877 | 15.45% | |
| ALMS |
Alumis Inc.
Healthcare
|
Added | 6,345,219 | $139,785,174 | 13.58% | |
| SEPN |
Septerna, Inc.
Healthcare
|
Held | 3,149,128 | $75,673,545 | 7.35% | |
| KLRS |
Kalaris Therapeutics, Inc.
Healthcare
|
Held | 12,948,081 | $74,710,427 | 7.26% | |
| SGP |
SpyGlass Pharma, Inc.
Healthcare
|
NEW | 2,109,953 | $54,668,882 | 5.31% | |
| NGNE |
Neurogene Inc.
Healthcare
|
Held | 1,717,127 | $34,617,280 | 3.36% | |
| IVA |
Inventiva S.A.
Healthcare
|
Held | 5,194,805 | $28,831,167 | 2.80% | |
| STRO |
Sutro Biopharma, Inc.
Healthcare
|
Added | 1,062,872 | $26,476,141 | 2.57% | |
| JBIO |
Jade Biosciences, Inc.
Healthcare
|
Held | 968,798 | $13,611,611 | 1.32% | |
| VTVT |
vTv Therapeutics Inc.
Healthcare
|
Held | 298,496 | $11,838,351 | 1.15% | |
| AQST |
Aquestive Therapeutics, Inc.
Healthcare
|
Held | 2,500,000 | $10,375,000 | 1.01% | |
| XFOR |
X4 Pharmaceuticals, Inc
Healthcare
|
Reduced | 1,832,566 | $7,568,497 | 0.74% | |
| NKTX |
Nkarta, Inc.
Healthcare
|
Held | 3,507,666 | $7,401,175 | 0.72% | |
| ACLX |
Arcellx, Inc.
Healthcare
|
Held | 60,873 | $6,989,437 | 0.68% | |
| UPB |
Upstream Bio, Inc.
Healthcare
|
Held | 736,047 | $6,624,423 | 0.64% | |
| ABVX |
Abivax S.A.
Healthcare
|
Reduced | 56,581 | $6,300,294 | 0.61% | |
| AGMB |
Agomab Therapeutics NV
Healthcare
|
NEW | 600,000 | $6,294,000 | 0.61% | |
| RANI |
Rani Therapeutics Holdings, Inc.
Healthcare
|
Held | 8,500,000 | $6,247,500 | 0.61% | |
| CHRS |
Coherus Oncology, Inc.
Healthcare
|
NEW | 3,428,571 | $5,794,284 | 0.56% | |
| PVLA |
Palvella Therapeutics, Inc.
Healthcare
|
Reduced | 38,432 | $4,790,548 | 0.47% | |
| GOSS |
Gossamer Bio, Inc.
Healthcare
|
Held | 7,222,559 | $2,376,221 | 0.23% |